CinCor Pharma, Inc.

CIK 1868734 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CinCor Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Mar 6, 202315-12G0001193125-23-060624
Mar 3, 2023SC 13D/A0001104659-23-028265
Mar 1, 2023SC 13D/A0001104659-23-027226
Feb 28, 2023SC 13D/A0000950142-23-000537
Feb 28, 2023SC 13D/A0001104659-23-026754
Feb 28, 202340001209191-23-013671
Feb 27, 202340001209191-23-013481
Feb 27, 202340001209191-23-013268
Feb 24, 2023SC 14D9/A0001193125-23-047405
Feb 24, 20238-K0001193125-23-047746
Feb 24, 202340001209191-23-012890
Feb 24, 202340001209191-23-012893
Feb 24, 2023SC TO-T/A0001104659-23-024916
Feb 24, 202340001209191-23-012898
Feb 24, 2023S-8 POS0001193125-23-047751
Feb 24, 202340001209191-23-012892
Feb 24, 202340001209191-23-012895
Feb 24, 202325-NSE0001354457-23-000111
Feb 24, 202340001209191-23-012891
Feb 24, 202340001209191-23-012899
Feb 23, 2023SC TO-T/A0001104659-23-024430
Feb 23, 2023SC 14D9/A0001193125-23-045540
Feb 21, 20238-K0001193125-23-043031
Feb 15, 2023SC 14D9/A0001193125-23-040287
Feb 14, 2023SC 13G0001193125-23-038710